Drug Profile
Research programme: anti-infective mRNA therapeutics - Moderna Therapeutics/Valera
Alternative Names: mRNA 1850; mRNA Therapeutics - Valera; mRNA Vaccines - ValeraLatest Information Update: 28 Jun 2022
Price :
$50
*
At a glance
- Originator Moderna Therapeutics
- Developer Valera LLC
- Class Bacterial vaccines; Parasitic vaccines; RNA vaccines; Viral vaccines
- Mechanism of Action Immunostimulants; Protein synthesis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Bacterial infections; HIV infections; Infections; Parasitic infections; Viral infections
Most Recent Events
- 28 Jun 2022 No recent reports of development identified for research development in HIV-infections(Prevention) in USA (Parenteral)
- 02 Jun 2020 Early research is ongoing for HIV-infections in USA (parenteral)
- 28 Feb 2020 No recent reports of development identified for preclinical development in Infections(Prevention) in USA (Parenteral)